Clinical Trial

Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic Diseases

Study acronym: PERIMED
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this cross-sectional observational study is to to perform a thorough characterization of the quantitative and qualitative differences in peripheral blood cells, and circulating factors (proteins, metabolites, lipids, extracellular vesicles) in different stages of several metabolic diseases (diabetes, obesity, non-alcoholic fatty liver disease) that share common pathophysiological mechanisms and in comparison with adult healthy controls. The main question\[s\] it aims to answer are: * Which are the quantitative (number and concentration) and qualtitative (characteristics, functional assays) differences in platelets in patients with metabolic diseases vs subjects without metabolic diseases * Which are the quantitative (number and concentration) and qualtitative (characteristics, functional assays) differences in leucocytes or circulating molecules in patients with metabolic diseases vs subjects without metabolic diseases
Trial Details
NCT Number NCT06396871
Lead Sponsor Technische Universität Dresden
Conditions NAFLD, Diabetes Mellitus, Obesity
Enrollment 180 participants
Start Date 2023-10-16
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-05-02